ALT
Price
$5.17
Change
+$0.20 (+4.02%)
Updated
Apr 24 closing price
Capitalization
398.16M
13 days until earnings call
TRDA
Price
$8.97
Change
+$0.26 (+2.99%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
336.85M
13 days until earnings call
Ad is loading...

ALT vs TRDA

Header iconALT vs TRDA Comparison
Open Charts ALT vs TRDABanner chart's image
Altimmune
Price$5.17
Change+$0.20 (+4.02%)
Volume$1.47M
Capitalization398.16M
Entrada Therapeutics
Price$8.97
Change+$0.26 (+2.99%)
Volume$2.39K
Capitalization336.85M
ALT vs TRDA Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. TRDA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Buy and TRDA is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ALT: $5.17 vs. TRDA: $8.96)
Brand notoriety: ALT and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 54% vs. TRDA: 87%
Market capitalization -- ALT: $398.16M vs. TRDA: $336.85M
ALT [@Biotechnology] is valued at $398.16M. TRDA’s [@Biotechnology] market capitalization is $336.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 1 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 1 green, 4 red.
According to our system of comparison, TRDA is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 3 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALT is a better buy in the short-term than TRDA.

Price Growth

ALT (@Biotechnology) experienced а +13.63% price change this week, while TRDA (@Biotechnology) price change was +10.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ALT is expected to report earnings on Aug 07, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALT($398M) has a higher market cap than TRDA($337M). ALT YTD gains are higher at: -28.294 vs. TRDA (-48.178). TRDA has higher annual earnings (EBITDA): 50.8M vs. ALT (-94.81M). TRDA has more cash in the bank: 420M vs. ALT (132M). ALT has less debt than TRDA: ALT (1.68M) vs TRDA (59.2M). TRDA has higher revenues than ALT: TRDA (211M) vs ALT (20K).
ALTTRDAALT / TRDA
Capitalization398M337M118%
EBITDA-94.81M50.8M-187%
Gain YTD-28.294-48.17859%
P/E RatioN/A5.33-
Revenue20K211M0%
Total Cash132M420M31%
Total Debt1.68M59.2M3%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
10
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
86
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTTRDA
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 11 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRLCX21.37N/A
N/A
Nuveen Large Cap Value Retire
BTBFX58.54N/A
N/A
Boston Trust Asset Management
FTPIX69.30N/A
N/A
Invesco Technology R5
HSMRX11.37N/A
N/A
Hartford Small Cap Value R3
CNGLX18.72N/A
N/A
Commonwealth Global

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
+2.87%
CRNX - TRDA
52%
Loosely correlated
+3.15%
ATXS - TRDA
52%
Loosely correlated
+0.19%
RXRX - TRDA
50%
Loosely correlated
+3.05%
ARCT - TRDA
49%
Loosely correlated
+1.90%
TECH - TRDA
48%
Loosely correlated
+1.24%
More